Packaging
Packaging
COMPOSICIÓN DE SOLUBILIZACIÓN FARMACÉUTICAMENTE ACEPTABLE Y FORMA DE DOSIFICACIÓN FARMACÉUTICA QUE CONTIENE LA MISMA.
04/03/2025 -
A pharmaceutically acceptable solubilizing composition comprising (i) at least one tocopheryl compound having a polyalkylene glycol moiety and (ii) at least one alkylene glycol fatty acid...
CONJUGADOS POLIMERICOS DEL FACTOR VIII.
05/03/2025 -
The invention is a proteinaceous construct comprising a Factor VIII molecule which is conjugated to a water-soluble polymer via carbohydrate moieties of Factor VIII, and methods of preparing same....
FORMULACION DE FARMACO DE LIBERACION RETARDADA QUE COMPRENDE UN NUCLEO Y UN RECUBRIMIENTO MULTICAPA PARA EL NUCLEO QUE COMPRENDE AL MENOS TRES CAPAS POLIMERICAS.
05/03/2025 -
Delayed release of a drug to the colon is achieved from a delayed release formulation comprising a core and a coating for the core. The core comprises a drug and the coating comprises an inner...
RISPERIDONE SOLID ORAL FILM, PREPARATION METHOD THEREFOR AND USE THEREOF
20/03/2025 -
A risperidone solid oral film. Each dosage unit of the oral film comprises: 0.10%-8.00% of risperidone, 5.00%-40.00% of a flavoring agent, 5.00%-40.00% of a stabilizer, 2.00%-15.00% of a...
PHARMACEUTICAL COMPOSITION AND BREXPIPRAZOLE ORALLY SOLUABLE FILM
20/03/2025 -
The present invention discloses a pharmaceutical composition and a brexpiprazole oral soluble film. The pharmaceutical composition comprises brexpiprazole, a film-forming material and a...
GLASS CONTAINERS FOR STORING PHARMACEUTICAL COMPOSITIONS
13/03/2025 -
Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an...
Crystalline form of deuruxolitinib phosphate
11/03/2025 -
The present disclosure is directed to polymorph Form 1 of 1H-pyrazole-1-propanenitrile, β-(cyclopentyl-2,2,3,3,4,4,5,5-d8)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)-, phosphate (1:1)...
3D PRINTING OF BIOLOGICS
06/03/2025 -
The present disclosure provides pharmaceutical compositions and methods of preparing pharmaceutical compositions containing an amino acid-based biologic through the use of 3D printing. These...
SUSTAINED-RELEASE FORMULATIONS FOR POORLY PERMEABLE CYCLIC PEPTIDES
27/02/2025 -
The present disclosure provides orally administered pharmaceutical compositions that are effective in providing sustained plasma levels of a therapeutic peptide in a subject. The disclosed...
Direct-Mold Blister Packaging System for Chocolate and Gummy Products
27/02/2025 -
The Direct-Mold Blister Packaging System for Chocolate and Gummy Products provides an integrated method and apparatus for the production and packaging of confectionery items. The system enables...
Formas polimorfas de aticaprant para su uso en el tratamiento del trastorno depresivo mayor.
24/01/2025 -
La divulgación proporciona formas cristalinas y amorfas de aticaprant. También se proporcionan composiciones farmacéuticas que comprenden las formas amorfas o cristalinas, métodos para el...
LID MATERIAL AND METHOD FOR MANUFACTURING SAME
13/02/2025 -
Provided are a lid material capable of reducing or suppressing the occurrence of a curl caused by a change in humidity and the occurrence of a blister during heat sealing, and a method for...
Ocular Device and Drug Delivery System, With Case
13/02/2025 -
An ocular device for placement under an eyelid that includes a plate with a back surface having at least one protrusion having a convex contact surface to contact the sclera of the eye and to...
ENHANCED DNA DENDRIMERS AND METHODS OF USE THEREOF
13/02/2025 -
The embodiments provide compositions comprising DNA dendrimers, targeting molecules, therapeutic agents, adaptor molecules, support molecules, or combinations thereof. Pharmaceutical compositions,...
N-N-DIMETILTRIPTAMINA (DMT) Y COMPOSICIONES ANÁLOGAS DE DMT, MÉTODOS DE FABRICACIÓN Y MÉTODOS DE USO DE ESTAS
29/01/2025 -
Se describen composiciones farmacéuticas que incluyen una N-N-dimetiltriptamina amorfa (DMT) o una sal o profármaco farmacéuticamente aceptable de esta, y un portador polimérico. Estas...
INHIBIDORES VIRALES, SÍNTESIS DE ESTOS E INTERMEDIOS DE ESTOS
15/01/2025 -
La presente divulgación describe composiciones que comprenden maribavir, métodos para proporcionar las mismas y composiciones que proporcionan intermedios útiles para proporcionar maribavir....
COMPOSITIONS FOR INTRODUCING RNA INTO CELLS
06/02/2025 -
The present invention relates to oligomers, polymers and lipidoids comprising characteristic oligo(alkylene amine) moieties which are useful as vehicles for transfecting a cell with RNA. The...
ENHANCED FORMULATION OF POLYMYXIN B/ TRIMETHOPRIM AND RIFAMPIN AND METHODS FOR OPHTHALMIC USES
06/02/2025 -
The invention provides novel pharmaceutical compositions of polymyxin B/trimethoprim and rifampin, as well as methods of their preparation and topical ophthalmic uses (e.g., treatment of...
PHARMACEUTICAL COMPOSITIONS, AND PREPARATION AND METHODS OF USE THEREOF
06/02/2025 -
The invention relates to pharmaceutical compositions or formulations and comprises (I) a compound of Formula (I) or Formula (II); (ii) one or more pharmaceutically acceptable polymers; and (iii)...
CRYSTALLINE HYDROCHLORIDE AND FUMARATE SALTS OF N-ETHYL-2- (5-FLUORO-1H-INDOL-3-YL)-N-METHYLETHAN-1-AMINE
06/02/2025 -
The present disclosure relates to a crystalline salt selected from crystalline N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine fumarate and crystalline...
Sistema de suministro de farmaco y metodos para usarlo
06/12/2024 -
Un método para preparar un biomaterial implantable que incluye combinar un polímero con un agente neuro-regenerativo o agente inmunosupresor seleccionado de un grupo que comprende al menos uno...
